INF108F in Infants With Food Protein Induced Proctocolitis

Description

Single-center, randomized, double-blind, placebo-controlled trail evaluating INF108F in breastfed infants with FPIAP

Conditions

Infant Development, Gut Microbiome, Food Protein Induced Allergic Proctocolitis

Study Overview

Study Details

Study overview

Single-center, randomized, double-blind, placebo-controlled trail evaluating INF108F in breastfed infants with FPIAP

Restoring Gut Health With INF108F in Infants With Food Protein Induced Allergic Proctocolitis

INF108F in Infants With Food Protein Induced Proctocolitis

Condition
Infant Development
Intervention / Treatment

-

Contacts and Locations

Newton

Newton Wellesley Hospital, Newton, Massachusetts, United States, 02462

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants, male or female, of all ethnic/racial groups, with a gestational period of 37 to 42 weeks
  • * Infants aged 1 - 90 days old with a documented FPIAP with either gross blood or microscopic blood in without other possible causes
  • * Infants must be exclusively breastfed or at least half of oral intake is from breast feeding or from expressed breast milk
  • * A willing parent or legal guardian will sign the consent form either electronically or with a wet ink signature
  • * Infants born earlier than 37 weeks of gestation
  • * Infants who are exclusively formula-fed or less than half of oral intake is from breastfeeding or from expressed breast milk at the time of enrollment
  • * Infants born with medical complications (i.e., neurological, cerebral palsy, confirmed food allergies)
  • * Diagnosis of other severe or complicating medical problems, including autoimmune or chronic immune inflammatory conditions, gastrointestinal inflammatory conditions, or renal insufficiency
  • * History of abdominal surgery or congenital abnormalities of the GI track, the cardiovascular system, the pulmonary system or the renal system
  • * Antibiotic use (oral or systemic) within 7 days prior to enrollment
  • * Mother's intent to feed non-study probiotics or solid food to their infant at any time during the study
  • * Mothers with substance use disorder (SUD) or on Nicotine replacement therapy (NRT)
  • * Infants who have consumed any B. infantis-containing probiotics since birth

Ages Eligible for Study

1 Day to 90 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Massachusetts General Hospital,

Study Record Dates

2024-03-01